CENTRE OSCAR LAMBRET
🇫🇷France
- Country
- 🇫🇷France
- Ownership
- Private
- Established
- 1995-01-01
- Employees
- 251
- Market Cap
- -
Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic Neuroblastoma
- First Posted Date
- 2009-08-18
- Last Posted Date
- 2016-08-08
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 30
- Registration Number
- NCT00960739
- Locations
- 🇫🇷
Hôpital des Enfants, Toulouse, France
🇫🇷Centre Oscar Lambret, Lille, France
🇫🇷Centre Léon Bérard, Lyon, France
Study of Blood Samples in Patients With Breast Cancer
- Conditions
- First Posted Date
- 2009-08-14
- Last Posted Date
- 2011-01-10
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 900
- Registration Number
- NCT00959556
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Study of Cerebrospinal Fluid Samples in Diagnosing Carcinomatous Meningitis in Patients With Cancer or Meningeal Syndrome
Not Applicable
- Conditions
- First Posted Date
- 2009-07-14
- Last Posted Date
- 2010-04-07
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 80
- Registration Number
- NCT00938756
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Research for Predictive Biologic Parameters of Cutaneous Hypersensitivity After Brachytherapy in Breast Cancer
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-17
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 25
- Registration Number
- NCT00922961
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Assessment of the Burden Within the Dyad Patient/Caregiver
- First Posted Date
- 2009-06-16
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 139
- Registration Number
- NCT00921232
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Assessment of Complications, Quality of Life and Easiness of Use of Implantable Central Venous Access Ports
Completed
- Conditions
- First Posted Date
- 2009-06-16
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 815
- Registration Number
- NCT00921141
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy
Not Applicable
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-03
- Last Posted Date
- 2012-07-31
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 66
- Registration Number
- NCT00911911
- Locations
- 🇫🇷
Intercommunal Hospital, Annemasse, France
🇫🇷Hopital Saint Vincent, Lille, France
🇫🇷Centre Oscar Lambret, Lille, France
Study About Preventive Treatment of Folliculitis Induced by Epidermal Growth Factor Receptor Inhibitors
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2012-07-31
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 30
- Registration Number
- NCT00910676
- Locations
- 🇫🇷
Centre Oscar Lambret, Lille, France
🇫🇷Centre Hospitalier Regional, Lille, France
🇫🇷Centre Hospitalier Régional, Lille, France
Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer
Phase 4
Completed
- Conditions
- First Posted Date
- 2009-06-01
- Last Posted Date
- 2012-01-02
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 50
- Registration Number
- NCT00911092
- Locations
- 🇫🇷
Centre Paul Papin, Angers, France
🇫🇷Centre François BACLESSE, Caen, France
🇫🇷Centre Oscar Lambret, Lille, France
Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-20
- Last Posted Date
- 2012-07-23
- Lead Sponsor
- Centre Oscar Lambret
- Target Recruit Count
- 89
- Registration Number
- NCT00905047
- Locations
- 🇫🇷
Centre Hospitalier Regional, Lille, France
🇫🇷Centre Hospitalier de CHOLET, Cholet, France
🇫🇷Centre Hospitalier, Valenciennes, France
© Copyright 2024. All Rights Reserved by MedPath